Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer

Fig. 7

The distribution and anti-cancer activity of PSVII@MCP-CaP in orthotopic drug-resistant colon cancer nude mice. A Fluorescence distribution in various organs and cancer tissue of orthotopic colon cancer mice observed by in vivo bioluminescence imaging (n = 3). B The average relative fluorescence intensity in organs (fluorescence intensity/organ weight) detected by spectrofluorometer. C In vivo bioluminescence imaging of orthotopic drug-resistant colon cancer nude mice. D Semi-quantitative statistical results of fluorescence intensity of orthotopic drug-resistant colon cancer tissue. E Visual images of orthotopic drug-resistant colon cancer tissue. F Tumor volume of orthotopic drug-resistant colon cancer tissue. All data are expressed as means ± SD (n = 5). **p < 0.01 vs Cy7.5-PSVII (12 h); ##p < 0.01 vs Cy7.5-PSVII (24 h); &p < 0.05, &&p < 0.01 vs model; $p < 0.05, $$p < 0.01 vs L-OHP

Back to article page